Kolb wrote to Treadway about an upcoming meeting to discuss dihydrodesoxymorphine-D, and noted that he felt it would be criminal to suggest that the new drug had no addiction potential.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)